Cargando…
Preclinical Studies of Mesenchymal Stem Cell (MSC) Administration in Chronic Obstructive Pulmonary Disease (COPD): A Systematic Review and Meta-Analysis
BACKGROUND: In the last two decades, mesenchymal stem cells (MSCs) have been pre-clinically utilized in the treatment of a variety of kinds of diseases including chronic obstructive pulmonary disease (COPD). The aim of the current study was to systematically review and conduct a meta-analysis on the...
Autores principales: | Liu, Xiangde, Fang, Qiuhong, Kim, Huijung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4900582/ https://www.ncbi.nlm.nih.gov/pubmed/27280283 http://dx.doi.org/10.1371/journal.pone.0157099 |
Ejemplares similares
-
Mesenchymal Stem Cell Administration in Patients with Chronic Obstructive Pulmonary Disease: State of the Science
por: Cheng, Shih-Lung, et al.
Publicado: (2017) -
Role of epithelial mesenchymal transition (EMT) in chronic obstructive pulmonary disease (COPD)
por: Sohal, Sukhwinder Singh, et al.
Publicado: (2013) -
Mesenchymal stem cell therapy in pulmonary fibrosis: a meta-analysis of preclinical studies
por: Li, Deng-Yuan, et al.
Publicado: (2021) -
Mesenchymal Stem Cells: Allogeneic MSC May Be Immunosuppressive but Autologous MSC Are Dysfunctional in Lupus Patients
por: Cheng, Rui-Juan, et al.
Publicado: (2019) -
A New Mesenchymal Stem Cell (MSC) Paradigm: Polarization into a Pro-Inflammatory MSC1 or an Immunosuppressive MSC2 Phenotype
por: Waterman, Ruth S., et al.
Publicado: (2010)